Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia

Original research

par

Brothers, Thomas D. et al

Date de publication

2022

Géographie

Australia

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Oui

Évalué par des pairs

Yes

L’objectif

Following hospitalization with an injecting-related infection, use of opioid agonist treatment (OAT; methadone or buprenorphine) may be associated with reduced risk of death or rehospitalization with an injecting-related infection.

Constatations/points à retenir

Following hospitalizations with injection drug use–associated bacterial and fungal infections, use of OAT is associated with lower risks of death and recurrent injecting-related infections among people with opioid use disorder.

La conception ou méthodologie de recherche

Data from the Opioid Agonist Treatment Safety (OATS)

doi.org

Mots clés

Hospitals

Substitution/OAT

Injecting drugs

Outcomes

About PWUD

Mortality